NewLimit Funding & Investors

NewLimit specializes in treating age-related diseases to extend the human health span. It works on developing epigenetic reprogramming medicines to treat diseases with large unmet needs.

Total Amount Raised: $40,000,000

NewLimit Funding Rounds

Series A
$40,000,000
May 15, 2023
Series A Investors
Eric Schmidt
Fred Ehrsam
Founders Fund
Dimension
Garry Tan
Kleiner Perkins
Elad Gil

Funding info provided by Diffbot.